Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors — Stella

Home/Spinal Tumor/

View on ClinicalTrials.gov

Recruiting

Back to Spinal Tumor trials

Trial locations(1 site)

China

Department of Radiation Oncology Cancer Center, Peking University Third Hospital 49# North Garden Rd.,Haidian Dist., Beijing, Beijing Municipality

Key details

Sponsor

Peking University Third Hospital

Enrollment target

~500 participants

Started

January 2017

Primary completion

December 2026

Age range

18 Years – 90 Years

Last updated September 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.